Daily Bulletin

Men's Weekly

.

PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020-PR Newswire APAC

DAEJEON, South Korea, Nov. 16, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) announced today that the company will present the final results of the Phase IIa clinical trial of Olinvacimab for rGBM (recurrent glioblastoma multiforme) patients at SNO (Society of Neuro-Oncology) 2020.

The clinical study was conducted in Australiafr...

Read more: PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020-PR Newswire APAC

Business News

Online Site Inductions for Busy HR Teams

Induct For Work, the Australian platform for frontline onboarding and compliance, has launched Compliance Hub, a fully integrated, real-time workflow designed specifically for the fast-paced, highly m...

Daily Bulletin - avatar Daily Bulletin

Reporting Tools in Cybersecurity and Penetration Testing

Reporting is a critical part of every penetration testing engagement. After vulnerabilities have been identified and verified, the findings must be documented clearly and systematically to inform deve...

Daily Bulletin - avatar Daily Bulletin

High-Quality Stainless Steel Suppliers in Melbourne | Stainless Trading Melbourne

Stainless steel plays a crucial role in modern industries due to its exceptional durability, outstanding corrosion resistance, and aesthetically pleasing appearance. It is used in many applications...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals